Paola Ballotari

ORCID: 0000-0003-4057-3535
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Migration, Health and Trauma
  • Selenium in Biological Systems
  • Diabetes Management and Education
  • Chronic Disease Management Strategies
  • Acute Lymphoblastic Leukemia research
  • Cancer Risks and Factors
  • Childhood Cancer Survivors' Quality of Life
  • Cervical Cancer and HPV Research
  • Diabetes Management and Research
  • Multiple and Secondary Primary Cancers
  • Diabetes Treatment and Management
  • Endometrial and Cervical Cancer Treatments
  • Metabolism, Diabetes, and Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Heavy Metal Exposure and Toxicity
  • Economic and Financial Impacts of Cancer
  • Trace Elements in Health
  • Primary Care and Health Outcomes
  • Glioma Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Lymphoma Diagnosis and Treatment
  • Obesity and Health Practices
  • Ocular Oncology and Treatments

Istituti di Ricovero e Cura a Carattere Scientifico
2015-2022

Azienda Sanitaria Unità Locale di Reggio Emilia
2013-2022

University of Modena and Reggio Emilia
2019

Ospedale Santa Maria
2015-2018

University of Padua
2015

Laura Botta Gemma Gatta Riccardo Capocaccia Charles Stiller Adela Cañete and 95 more Luigino Dal Maso Kaire Innos Ana Mihor Friederike Erdmann Claudia Spix Brigitte Lacour Rafael Marcos‐Gragera Deirdre M. Murray Silvia Rossi Monika Hackl E. Van Eycken Nancy Van Damme Z. Valerianova Mario Šekerija Vasos Scoutellas Anna Demetriou Ladislav Dušek Denisa Krejčí Hans H. Storm Margit Mägi Kaire Innos Keiu Paapsi Nea Malila Janne Pitkäniemi Valérie Jooste Jacqueline Clavel Claire Poulalhon Brigitte Lacour Emmanuel Désandes Alain Monnereau Friederike Erdmann Claudia Spix Alexander Katalinic Eleni Petridou Georgios Markozannes Miklós Garami Helgi Birgisson Deirdre M. Murray Paul Walsh Guido Mazzoleni Fabio Vittadello Francesco Cuccaro Rocco Galasso Giuseppe Sampietro Stefano Rosso C. Gasparotto Giovanni Maifredi Margherita Ferrante Antonina Torrisi Antonella Sutera Sardo Maria Letizia Gambino Monica Lanzoni Paola Ballotari Erica Giacomazzi Stefano Ferretti Adele Caldarella Gianfranco Manneschi Gemma Gatta Milena Sant Paolo Baili Franco Berrino Laura Botta Annalisa Trama Roberto Lillini Alice Bernasconi S. Bonfarnuzzo Claudia Vener Fabio Didonè Paolo Lasalvia G. Monego Lucia Buratti Diego Serraino Martina Taborelli Riccardo Capocaccia Roberta De Angelis Elena Demuru Corrado Di Benedetto Silvia Rossi Mariano Santaquilani Serenella Venanzi Marco Tallon Luca Boni Silvia Iacovacci Antonio Russo Federico Gervasi Gianbattista Spagnoli Luca Cavalieri d'Oro Mario Fusco Maria Francesca Vitale Mario Usala Francesco Vitale Maria Michiara Giorgio Chiranda Carlotta Sacerdote Milena Maule

10.1016/s1470-2045(22)00637-4 article EN publisher-specific-oa The Lancet Oncology 2022-11-16
Roberta De Angelis Elena Demuru Paolo Baili Xavier Troussard Alexander Katalinic and 95 more María Dolores Chirlaque López Kaire Innos Mariano Santaquilani Marcel Blum Leonardo Ventura Keiu Paapsi Rocco Galasso Marcela Guevara Giorgia Randi Manola Bettio Laura Botta Stefano Guzzinati Luigino Dal Maso Silvia Rossi Monika Hackl E. Van Eycken Nancy Van Damme Z. Valerianova Mario Šekerija Vasos Scoutellas Anna Demetriou Ladislav Dušek Denisa Krejici Hans H. Storm Margit Mägi Kaire Innos Janne Pitkäniemi Michel Velten Xavier Troussard Anne‐Marie Bouvier Valérie Jooste Anne‐Valérie Guizard Guy Launoy Sandrine Dabakuyo Yonli Marc Maynadié Anne‐Sophie Woronoff Jean‐Baptiste Nousbaum Gaëlle Coureau Alain Monnereau Isabelle Baldi Karima Hammas Brigitte Trétarre Marc Colonna Sandrine Plouvier Tania d’Almeida F. Molinié Anne Cowppli‐Bony Simona Bara Adeline Debreuve Gautier Défossez B. Lapôtre‐Ledoux Pascale Grosclaude Laëtitia Daubisse‐Marliac Sabine Luttmann Roland Stabenow Alice Nennecke Joachim Kieschke Sylke Ruth Zeißig Bernd Holleczek Alexander Katalinic Helgi Birgisson Deirdre M. Murray Paul M. Walsh Guido Mazzoleni Fabio Vittadello Francesco Cuccaro Rocco Galasso Giuseppe Sampietro Stefano Rosso Cinzia Gasparotti Giovanni Maifredi Margherita Ferrante Rosalia Ragusa Antonella Sutera Sardo Maria Letizia Gambino Monica Lanzoni Paola Ballotari Erica Giacomazzi Stefano Ferretti Adele Caldarella Gianfranco Manneschi Gemma Gatta Milena Sant Paolo Baili Franco Berrino Laura Botta Annalisa Trama Roberto Lillini Alice Bernasconi S. Bonfarnuzzo Claudia Vener Fabio Didonè Paolo Lasalvia Lucia Buratti Giovanna Tagliabue

10.1016/s1470-2045(23)00646-0 article EN The Lancet Oncology 2024-01-30

Aim of this study was to compare cancer incidence in populations with and without diabetes by site. Furthermore, we aimed at comparing excess risk according type, duration treatment, the latter as regards Type 2 diabetes.By use Reggio Emilia registry classified resident population aged 20-84 December 31st 2009 into two groups: diabetes. By linking calculated 2010-2013 both groups. The rate ratios (IRR) site, type diabetes, duration, concerns treatment regimen were computed using Poisson...

10.1186/s12885-017-3696-4 article EN cc-by BMC Cancer 2017-10-25

•Italy will have 4 million cancer survivors in 2030 (6.9% of the population), half diagnosed at least 10 years earlier.•From 2018 to 2030, complete prevalence increase by 1.5% per year.•As many as 7 out 8 prevalent cases same life expectancy general population.•Ten after diagnosis, 96% not die from cancer.•Prevalence estimates are essential improve consistent, data-driven control planning. BackgroundThe number and projections necessary meet healthcare needs patients, while data on cure...

10.1016/j.esmoop.2024.103635 article EN cc-by-nc-nd ESMO Open 2024-07-01
Milena Sant Claudia Vener Roberto Lillini Silvia Rossi S. Bonfarnuzzo and 95 more Rafael Marcos‐Gragera Marc Maynadié Kaire Innos Keiu Paapsi Otto Visser Alice Bernasconi Elena Demuru Corrado Di Benedetto Seyed Mohsen Mousavi Marcel Blum Philip Went Diego Serraino Damien Bennett María‐José Sánchez Roberta De Angelis Monika Hackl E. Van Eycken Nancy Van Damme Z. Valerianova Mario Šekerija Vasos Scoutellas Anna Demetriou Ladislav Dušek Denisa Krejici Hans H. Storm Margit Mägi Kaire Innos Janne Pitkäniemi Michel Velten Xavier Troussard Anne‐Marie Bouvier Valérie Jooste Anne‐Valérie Guizard Guy Launoy Sandrine Dabakuyo Yonli Marc Maynadié Anne‐Sophie Woronoff Jean‐Baptiste Nousbaum Gaëlle Coureau Alain Monnereau Isabelle Baldi Karima Hammas Brigitte Trétarre Marc Colonna Sandrine Plouvier Tania d’Almeida F. Molinié Anne Cowppli‐Bony Simona Bara Adeline Debreuve Gautier Défossez B. Lapôtre‐Ledoux Pascale Grosclaude Laëtitia Daubisse‐Marliac Sabine Luttmann Andrea Eberle Roland Stabenow Alice Nennecke Joachim Kieschke Sylke Ruth Zeißig Bernd Holleczek Alexander Katalinic Helgi Birgisson Deirdre M. Murray Paul Walsh Guido Mazzoleni Fabio Vittadello Francesco Cuccaro Rocco Galasso Giuseppe Sampietro Stefano Rosso Cinzia Gasparotti Giovanni Maifredi Margherita Ferrante Rosalia Ragusa Antonella Sutera Sardo Maria Letizia Gambino Monica Lanzoni Paola Ballotari Erica Giacomazzi Stefano Ferretti Adele Caldarella Gianfranco Manneschi Gemma Gatta Milena Sant Paolo Baili Franco Berrino Laura Botta Annalisa Trama Roberto Lillini Alice Bernasconi S. Bonfarnuzzo Claudia Vener Fabio Didonè Paolo Lasalvia

10.1016/s1470-2045(24)00141-4 article EN The Lancet Oncology 2024-05-01

The aim of the study is to assess sex difference in association between type 2 diabetes and incidence major cardiovascular events, that is, myocardial infarction, stroke, heart failure, using information retrieved by register. inhabitants Reggio Emilia (Italy) aged 30–84 were followed during 2012–2014. Incidence rate ratios 95% confidence intervals calculated multivariate Poisson model. age- sex-specific event rates graphed. Subjects with had an excess risk compared their counterparts...

10.1155/2017/6039356 article EN cc-by International Journal of Endocrinology 2017-01-01

The objective of this study is to assess the impact diabetes on cardiovascular mortality, focusing sex differences. inhabitants Reggio Emilia province December 31, 2009, aged 20–84 were followed up for three years mortality. exposure was determined using register. age-adjusted death rates estimated as well incidence rate ratios Poisson regression model. Interaction terms and tested by Wald test. People with had an excess compared nondiabetic subjects (all cause: IRR = 1.68; 95%CI 1.60–1.78;...

10.1155/2015/914057 article EN cc-by International Journal of Endocrinology 2015-01-01

To describe the procedures to derive complete prevalence and several indicators of cancer cure from population-based registries. Cancer registry data (47% Italian population) were used calculate limited duration for 62 types by sex registry. The incidence survival models, needed completeness index (R) prevalence, evaluated likelihood ratio tests visual comparison. A sensitivity analysis was conducted explore effect on using different R indexes. Mixture models estimate net (NS); life...

10.3389/fonc.2023.1168325 article EN cc-by Frontiers in Oncology 2023-06-06

Abstract People alive many years after breast (BC) or colorectal cancer (CRC) diagnoses are increasing. This paper aimed to estimate the indicators of cure and complete prevalence for Italian patients with BC CRC by stage age. A total 31 Cancer Registries (47% population) data until 2017 were included. Mixture models allowed estimation net survival (NS); fraction (CF); time (TTC, 5‐year conditional NS >95%); (who will not die cancer); already cured (prevalent living longer than TTC). 2.6%...

10.1002/ijc.34923 article EN cc-by-nc-nd International Journal of Cancer 2024-03-23

Abstract This study aims to estimate long-term survival, cancer prevalence, and several cure indicators for Italian women with gynecological cancers. Thirty-one registries, representing 47% of the female population, were included. Mixture models used net fraction, time (when 5-year conditional survival becomes > 95%), prevalence (women who will not die cancer), already cured (living longer than cure). In 2018, 0.4% (121 704) alive after diagnosis corpus uteri cancer, 0.2% (52 551)...

10.1093/aje/kwae044 article EN cc-by-nc American Journal of Epidemiology 2024-04-09

The diabetes prevalence increases at an alarming rate around the world and understanding disparities in occurrence, care management, health outcomes may be a starting point towards achieving more effective strategies to prevent manage it. aims of this study are compare immigrants Italians terms differences evaluate inequalities disease management glycaemic control by using information included Reggio Emilia register. We retrieved from register subjects aged 20–74 on December 31st, 2009....

10.1186/s12889-015-1403-4 article EN cc-by BMC Public Health 2015-02-05

Background/Objectives: The increasing incidence of cancer during pregnancy is a growing public health concern, driven by delayed parenthood and rising maternal age. Pregnancy-associated (PAC) presents complex clinical challenges, necessitating balance between treatment fetal safety. Historically considered incompatible with favorable outcomes, evidence now suggests that can often proceed without affecting prognosis. A 2022 study in Italy provided the first population-based PAC estimates...

10.3390/cancers17071230 article EN Cancers 2025-04-05
Alice Bernasconi Angela Toss Emma Zattarin Seyed Mohsen Mousavi Marcel Blum and 95 more Claudia E. Kuehni Alexander Katalinic Jan Trallero Elisabetta Rapiti Luigino Dal Maso Laura Botta Silvia Rossi Fedro A. Peccatori Annalisa Trama Monika Hackl Erik V. Van der Eycken Nancy Van Damme Z. Valerianova Mario Šekerija Irene Gregoriou A Demetriou Ladislav Dušek Denisa Krejici H. Storm Margit Mägi Kaire Innos Janne Pitkäniemi M. Velten X. Troussard Anne‐Marie Bouvier Valérie Jooste N Vigneron G. Launoy Sandrine Dabakuyo Yonli Marc Maynadié Anne‐Sophie Woronoff Jean‐Baptiste Nousbaum Gaëlle Coureau Alain Monnereau Isabelle Baldi Karima Hammas B. Tretarre Michele Rosario Colonna Sandrine Plouvier Tania d’Almeida F. Molinié A. Cowppli-Bony S. Bara Adeline Debreuve Gautier Défossez B. Lapôtre‐Ledoux L. Daubisse-Marliac Sébastien Lamy Sabine Luttmann Andrea Eberle Roland Stabenow A. Nennecke Florian Peters Joachim Kieschke Sylke Ruth Zeißig B. Holleczek Alexander Katalinic H. Birgisson Deirdre M. Murray Giorgia Mazzoleni Fabio Vittadello Francesco Cuccaro Rocco Galasso Gianluca M. Sampietro Stefano Rosso Cinzia Gasparotti Giovanni Maifredi M. Ferrante Rosalia Ragusa Angela Sardo Maria Letizia Gambino Monica Lanzoni Paola Ballotari Erica Giacomazzi Stéphane Ferretti Adele Caldarella Gianfranco Manneschi Gemma Gatta M. Sant Paolo Baili F. Berrino Laura Botta Annalisa Trama R. Lillini Alice Bernasconi S. Bonfarnuzzo Claudia Vener Fabio Didoné Paolo Lasalvia Laura Buratti Giovanna Tagliabue Fabiola Giudici Luigino Dal Maso Riccardo Capocaccia R. De Angelis

10.1016/j.breast.2025.104472 article EN The Breast 2025-05-01

The primary aim of this study was to assess the effect immigrant status on Emergency Room (ER) utilisation by children under age one, considering all, non-urgent, very urgent, and followed hospitalisation visits. second investigate role played mother's educational level in relationship between citizenship ER utilisation. cohort included all healthy singleton live births years 2008–2009 residing province Reggio Emilia, for first year life order their outcomes were rate main explanatory...

10.1186/1472-6963-13-458 article EN cc-by BMC Health Services Research 2013-11-01

(1) Objective: In many Western countries, survival from vulvar squamous cell carcinoma (VSCC) has been stagnating for decades or increased insufficiently a clinical perspective. Italy, previous studies on cancer have not taken into consideration pooled patients with and vaginal cancer. To bridge this knowledge gap, we report the trend in between 1990 2015. (2) Methods: Thirty-eight local registries covering 49% of national female population contributed records 6274 patients. Study endpoints...

10.3390/jcm12062172 article EN Journal of Clinical Medicine 2023-03-10

Objective: To evaluate short-term (2008–2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and type. Methods: Observational study from population-based data collected 20 Italian Cancer Registries, covering 33% of the population. The age-standardized rates (ASRs), overall stratified area, sex, site or type, major age groups (i.e., 20-39, 40-49), were computed. Results: In 2008-2017, almost two times higher women than age-corresponding men (202.2 vs 112.4 per...

10.1177/03008916241297078 article EN Tumori Journal 2024-11-15

To assess the effect of insulin on cancer incidence in type 1 (T1DM) and 2 diabetes (T2DM).The cohort included all 401,172 resident population aged 20-84 December 2009 still alive 2011, classified for DM status. Drug exposure was assessed 2009-2011 follow up conducted from 2012 to 2016 through registry. Incidence rate ratios (IRRs) were computed sites most frequent sites.among residents, 21,190 people had diabetes, 2282 whom taking insulin; 1689 cancers occurred, 180 among users. The risk...

10.3390/cancers14112719 article EN Cancers 2022-05-31

The Italian Network of Longitudinal Metropolitan Studies (IN-LiMeS) is a system integrated data on health outcomes, demographic and socioeconomic information, represents powerful tool to study inequalities.IN-LiMeS multicentre multipurpose pool metropolitan population cohorts enrolled in nine cities: Turin, Venice, Reggio Emilia, Modena, Bologna, Florence, Leghorn, Prato Rome. Data come from record linkage municipal registries, the 2001 census, mortality registers hospital discharge...

10.1136/bmjopen-2017-020572 article EN cc-by-nc BMJ Open 2018-04-01
Coming Soon ...